Product image of Xospata (Gilteritinib) supplied by GNH India

Xospata

Active Ingredient:
Gilteritinib
Origin:
EU

Xospata (Gilteritinib)

Xospata (gilteritinib) is an oral prescription medication used to treat certain types of acute myeloid leukemia (AML). It belongs to a class of drugs known as tyrosine kinase inhibitors. This medication helps slow the growth of cancer cells in the body.

Manufacturer / TM Owner

Astellas Pharma Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Xospata (gilteritinib) is primarily used to treat adults with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation called FLT3. It works by blocking signals that promote cancer cell growth. This medication is often prescribed when standard treatments have not been effective. Patients may ask, 'what is Xospata used for' or 'how does gilteritinib treat AML'.

Side Effects

  • Xospata (gilteritinib) is taken orally and works systemically to target cancer cells. Common effects include gastrointestinal discomfort, fatigue, and changes in blood cell counts. Some patients may experience nausea, diarrhea, or swelling in the hands or feet. These effects vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

  • Xospata should be taken exactly as prescribed by a healthcare professional. It is important to discuss your full medical history, including any liver or kidney conditions, before starting this medication. Regular blood tests are typically required to monitor your body’s response. Avoid grapefruit products while taking Xospata, as they may interact with the drug.

Avoid Interactions

  • Xospata can interact with other medications, including certain antibiotics, antifungals, and herbal supplements. Strong CYP3A4 inhibitors or inducers may alter how Xospata works in the body. Alcohol and grapefruit products should be avoided due to potential interactions. Always inform your doctor about all medications and supplements you are taking.

Frequently Asked Questions

Xospata is used to treat relapsed or refractory acute myeloid leukemia (AML) in adults with a FLT3 mutation.

Xospata is an oral medication, typically taken once daily with or without food as directed by a doctor.

Common side effects may include nausea, fatigue, diarrhea, and changes in blood cell counts.

No, grapefruit products should be avoided as they may interact with Xospata.

No, Xospata is a targeted therapy known as a tyrosine kinase inhibitor, not a traditional chemotherapy.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Gilteritinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT